Red List

SPRYARS Pharmaceuticals, Inc.

Healthcare · Biotechnology · small-cap ($563M)
-63.4%
from rolling 252-day high of $16.65 set 2025-08-13 · 365d ago
Current
$6.10
Decline depth
-63.4%
Decline σ
4.1σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$SPRY has been tracked since 2026-03-01. It was down 51.5% from its 52-week high then — now down -63.4%.

That's 18.6 percentage points deeper than the day it joined.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

SPRY qualifies for the Red List on decline depth.

Decline depth
-63.4%
From rolling 252-day high of $16.65, 365d ago. Past the 40% Red List threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
4.1σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (4.73% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about SPRY.

SPRY qualifies for the Red List on decline depth — down -63.4% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 4.1σ over 20 bars.

Earnings on file: 2026-05-15. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about SPRY

What people ask.

Why is SPRY on Broken Stocks?

SPRY qualifies for the Red List on decline depth. It is down -63.4% from its rolling 252-day high of $16.65, set on 2025-08-13 — 365d ago.

Is SPRY a falling knife?

Not by the strict technical definition. SPRY is down -63.4% from its 52-week high, but that high was set 365d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. SPRY is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is SPRY a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is SPRY trading inside its 52-week range?

At $6.10, SPRY sits 3.7% of the way from its 52-week low ($5.62) to its 52-week high ($18.50). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has SPRY been declining?

The current 63.4% decline accrued over 365d, which annualizes to roughly -63.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does SPRY compare to its sector?

There are 140 other Healthcare tickers on Broken Stocks: 67 Red, 34 Amber, 39 Watch, with 48 showing recovering structural signals. Median sector decline is -35.8% — SPRY's decline is deeper than the sector median.

Does SPRY's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-15) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.